Boston Scientific (BSX) free cash flow

Free cash flow · fiscal 2025
$3.40B

Boston Scientific (BSX) generated free cash flow of $3.40B in fiscal 2025 (the year ended December 31, 2025). That is 43.9% higher than the $2.37B of fiscal 2024. Figures as of 18 Nov 2026, 12:33 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Free cash flow, fiscal 2025
$3.40B
Change on fiscal 2024
+43.9%
Growth, 5 years
+24.6% a year
Growth, 10 years
+22.6% a year
Highest on record
$3.40Bfiscal 2025
Lowest on record
-$6.00Mfiscal 2018
Fiscal years on record
192007–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Boston Scientific free cash flow, in more detail

Over the five fiscal years to 2025 free cash flow grew at a compound 24.6% a year; over ten years the rate was 22.6% a year. Across the 19 fiscal years on record (2007–2025), the highest was $3.40B in fiscal 2025 and the lowest -$6.00M in fiscal 2018.

History · 19 fiscal years

Free cash flow by fiscal year

Boston Scientific free cash flow, year by year

Boston Scientific (BSX) free cash flow by fiscal year
Fiscal yearFree cash flowChangeYear ended
2025$3.40B 43.9% up
2024$2.37B 38.9% up
2023$1.70B 86.3% up
2022$914.00M 30.5% down
2021$1.32B 16.3% up
2020$1.13B 17.7% down
2019$1.38B—
2018-$6.00M 100.5% down
2017$1.11B 37.3% up
2016$806.00M 81.5% up
2015$444.00M 56.0% down
2014$1.01B 16.8% up
2013$865.00M 17.9% down
2012$1.05B 49.7% up
2011$704.00M 1,228.3% up
2010$53.00M 89.9% down
2009$523.00M 38.8% down
2008$854.00M 49.6% up
2007$571.00M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement.

How to read it

It is the cash left for dividends, buybacks, debt repayment and acquisitions; profit that never turns into free cash flow deserves a second look.

Free cash flow at health care companies of similar size

Free cash flow of Boston Scientific and comparable companies
CompanyFree cash flowFiscal year
Takeda Pharmaceutical TAK¥626.77B2026
Boston Scientific BSX$3.40B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on BSX

Boston Scientific, figure by figure

Boston Scientific (BSX) overview: price, valuation and scorecardAll health care companies by market value

Boston Scientific free cash flow: questions and answers

What is Boston Scientific's free cash flow?

Boston Scientific (BSX) generated free cash flow of $3.40B in fiscal 2025 (the year ended December 31, 2025). That is 43.9% higher than the $2.37B of fiscal 2024.

What is the growth rate of Boston Scientific's free cash flow?

Over the five fiscal years to 2025 free cash flow grew at a compound 24.6% a year; over ten years the rate was 22.6% a year.

What are the highest and lowest free cash flow figures on record for Boston Scientific?

Across the 19 fiscal years on record (2007–2025), the highest was $3.40B in fiscal 2025 and the lowest -$6.00M in fiscal 2018.

How is Boston Scientific's free cash flow calculated?

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement. For Boston Scientific it is on record here for 19 fiscal years, 2007 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Boston Scientific (BSX) free cash flow”, data as of 18 November 2026. https://funkfolio.com/stock/BSX/free-cash-flow

Underlying data: the company's filings with the SEC and Yahoo Finance.